The Journal of Phytopharmacology, 2022;11(6):425-431 DOI:10.31254/phyto.2022.11609
Lupeol: An Alternative Approach towards Cancer Treatment
Devender Sharma1 , Niraj Gupta2
1. Research Scholar, School of Pharmacy, OPJS University, Churu, Rajasthan, India
2. Associate Professor, College of Pharmacy Agra, Dr. A.P.J. Abdul Kalam Technical University, Lucknow, Uttar Pradesh
*Author to whom correspondence should be addressed.
Received: 3rd October, 2022 / Accepted: 19th November, 2022 / Published : 20th December, 2022
Cancer is a broad word for a group of neoplastic illnesses defined by changes in a cell's structure that cause it to proliferate abnormally. There are about 200 cancers detected in human body. Each type of carcinoma has different indications and symptoms, as well as different treatments. Lupeol 280 mg/g dried leafs is a chemical component found in aloe leaves. Lupeol is a triterpene active in both food and medicine. Over the last decade, an unprecedented massive increase in involvement in triterpene as a result of their cholesterol-lowering properties. The products based on triterpene are commercially over sold in the world due to its heavy demand of use. Fagarsterol another name for the chemical lupeol. It's found in foods like Brassica oleracea var. capitata, Capsicum annuum Group, Fragaria, Olea europaea, Mangifera indica, Vitis vinifera, Aloe barbandesismiller, Semaltreeetc. Lupeol was already demonstrated to be an efficient curative and protective constituent for a wide range of disorders. It is an anti-carcinogenic and curative compound. Many developments have been so far with respective lupeol dosage formulation to increase bioavailability and pharmacological effect. This manuscript also provides deep inside of recent patents associated with lupeol in past decade.
Cancer, Leukemia, Lymphoma, Myeloma, Lupeol, Aloe vera
HOW TO CITE THIS ARTICLE
Sharma D, Gupta N. Lupeol: An Alternative Approach towards Cancer Treatment. J Phytopharmacol 2022; 11(6):425-431. doi: 10.31254/phyto.2022.11609
Creative Commons (CC) License-
This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY 4.0) license. This license permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.(http://creativecommons.org/licenses/by/4.0/).
Copyright
Copyright © 2022 Author(s) retain the copyright of this article. This article is published under the terms of the Creative Commons Attribution Liscense 4.0.